Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Syncona
Biotech
Syncona adds two cancer biotechs to growing portfolio
Syncona has added two cancer companies to its portfolio, ensuring the biotechs are armed with a total of over $100 million in series A and B funds.
James Waldron
Jun 20, 2024 8:37am
Syncona merges Freeline, SwanBio into new gene therapy biotech
Jun 17, 2024 11:01am
Syncona throws lifeline to Freeline by buying struggling biotech
Nov 22, 2023 9:40am
Freeline, facing fading cash runway, mulls buyout by Syncona
Oct 19, 2023 10:00am
Syncona blames difficult market for falling biotech valuations
Jun 15, 2023 9:20am
Amarin CEO abruptly resigns—Chutes & Ladders
Apr 7, 2023 9:30am
